We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Schroder Uk Public Private Trust Plc | LSE:SUPP | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.725 | 14.25 | 15.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/10/2020 07:26 | Just over 14 months to go to the S-Juniors' self-imposed deadline to completely revamp SUPP. Seen nothing more on the Schroders British Opportunities Trust, aiming to raise £250m - can they twist enough arms? Seems to be the only hope. Buffetology IT been pulled this morning after not even reaching the minimum. | spectoacc | |
25/10/2020 14:07 | Ironically, I have already been pm'ed by three separate posters saying that they wished to post in support of my remarks but can't, because they have been prevented by jonwig! | johnwig | |
23/10/2020 19:26 | Blackrock appear to have upped their stake to over 10pct per that rns... | scrapheap | |
18/10/2020 10:17 | Yeah spectoacc is a bit out of place in the shareprophets galère, what with those dodgy Oxford graduates and Blues and apparently reformed Dartmoor characters. He so desperately needs to be regarded as a money expert. Alas, nobody seems to believe that he knows anything at all. That's why he is on a de minimum wage, LOL. | mochyn | |
15/10/2020 14:11 | The problem for him is that the structure is still terrible. That has not changed. But with ON still seemingly in the portfolio along with a decent healthcare weighting, it's not dead either. But its future seems unlikely to be an investment trust called SUPP - IMO. If they can realise the current share price, or maybe a bit more) and exchange SUPP shares for units in something related, they may be able to keep investors on board and also keep their performance targets. Speculation on my part. | chucko1 | |
15/10/2020 11:41 | Did anyone watch Tim Creed on the Quoted Data 'Growth Strategies' conference on Wednesday? It'll be on their YouTube channel. Probably the same deck he did for investors a few weeks ago, which I missed. I was very impressed by him (I am easily impressed). He is very smart, has a clear plan, and remains bullish on SUPP's prospects (which is good, given their 77p share price performance hurdle), albeit not within a short timescale. Maybe not in my lifetime though and I'm not planning to shuffle off for 30 years. | lewis121 | |
14/10/2020 14:54 | I wonder what position spectoacc holds at shareprophets. Probably bog-cleaner (minimum wage) or possibly general factotum or, more likely, generally facall. LOL | pete_bane | |
13/10/2020 21:06 | Thanks @kooba. Agree ON is a rare bright spot for SUPP - let's hope it wasn't them slotting a few again! | spectoacc | |
13/10/2020 16:50 | Same level as last valuation as effectively increasing size of last funding ..also accommodating some existing holders selling where they are under redemption pressure I believe..Invesco still in.I don't think this raise should been seen as reflecting the progress in the company which now has a whole new business on top of the sequencing platform since the start of the year in Diagnostics. I think there is still talk of IPO in the new year which I would expect to be multiples of current valuation. But the company now has funding to ramp up production of the Lampore test which I think will expand further in the testing protocol here and abroad.It can take a saliva test , doesn't use same reagents as most PCR tests which are having supply issues and has the capacity to diagnose not just CVD19 but if other pathogens present ..ie if you have common or garden flu.Bit of a game changer. | kooba | |
13/10/2020 07:22 | ON raised more cash, can't see at what valuation tho? Any higher than last raise? | spectoacc | |
08/10/2020 13:51 | Venturing OT but it's a good read - and a couple of mentions for ON: | spectoacc | |
08/10/2020 12:48 | Who's to say it's an uplift... ;) Tho did like "The deal happened Monday 5th Oct, we'll put it into the next NAV ending 30th Sept". On the plus side - it's not another wipeout. | spectoacc | |
08/10/2020 10:40 | lewis - Schroders is another country; they do things differently there. I see Seedrs is 1.7% of the SUPP portfolio. Is the likely uplift worth putting into a full-cost RNS? (Around £500 I think.) | jonwig | |
08/10/2020 10:30 | Re. today's Seedrs announcement, why do SUPP call it private equity? It's VC isn't it? Do they not understand the difference? That was the problem Woody had. | lewis121 | |
07/10/2020 16:24 | Whether Schroders get this new fund off the ground seems key (anyone would be mad to invest in it, but SUPP shows they're tapping a big market) - but good point about further write-downs. Will also be interesting to see which they cherry-pick, if it happens. If it doesn't happen, the Schroder Juniors' "This time next year" will be tricky. | spectoacc | |
07/10/2020 14:36 | There's another,very amusing, takedown of the fool spectoacc on the corrupt thread. | kpo115 | |
07/10/2020 14:31 | I had noticed this. Ominous. I looked over the analysis by JPM and saw little to spark optimism. More the opposite, although I still see a path to redemption, but as part of a new fund. Were that the case, the JPM comment about triaging the line items still requiring investment might lead to further write-downs prior to this action as new investors would not stomach anything else. Loan matures Jan 2021 so I suppose Schroders may have stabilised the situation, but I really cannot see why anyone should be bothered with this as an investment in healthcare and bio. They are 64% in that sector, and yet achieved nothing. Other funds, as I have said before, are up 30% or so. I would go so far as to say that you would have to be a fool to think otherwise. Accept this investment is not much good and move on. If you can. | chucko1 | |
07/10/2020 14:14 | I knew it, Spectoacc, of course. Is it only now you are finding out? Bloody hell man, quite soon you'll be telling us you know the value of every single share in the SUPP portfolio. (Whereas the rest of us are totally aware that you do not, can not know the value of any! How could you? LOL) By the way, you keep on using Latin phrases about which you also know nothing. For instance you have, several times, used the phrase "de minimus". I think the actual phrase you are fumbling for is "de minimis". All serious investors will know that the Latin preposition "de" takes the ablative (in this instance plural) and not, as you aver, the nominative (singular). The full phrase (mediaeval not really classical Latin)is "de minimis non curat lex". Loosely translated it means "The law does not care about small trivial matters". You should take care that, next time you try to use a Latin phrase, you know how to spell it and know what it means. Otherwise you will, once again, be seen as ignorant as well as self-important. P.S."slotted" is another basically unknown idiom. Is it common in the West Riding? | johnwig | |
07/10/2020 12:45 | Just as an aside - did we know this? - SUPP slotted some ON in May at that fundraising that also saw IPO sell down. | spectoacc | |
07/10/2020 12:35 | Lol! Porsche still has illusions that companies treat shareholders fairly, rather than ascannon fodder. | jonwig | |
07/10/2020 12:26 | Porsche, nice to see you more bullish than usual. | chucko1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions